Altria Group (NYSE:MO) has appointed Salvatore Mancuso to its Board of Directors. The company announced that Mancuso is ...

Altria’s fourth quarter results drew a negative market reaction, largely due to a pronounced decline in operating margin ...

FDA approvals and acquisitions bolster Altria's smoke-free transition. Find out why MO stock offers compelling value and ...

So, should you buy or sell Altria stock after the recent decline? Before addressing this, if you are looking for an upside ...

Shares of Altria dipped Thursday after the tobacco giant reported flat earnings due to declining cigarettes sales and ...

Altria Group, Inc. expects continued growth in adjusted diluted EPS and in dividends until 2028. Click here to read why MO ...

More people are turning to oral tobacco products for their nicotine needs. Yet here, too, Altria is failing to keep pace with ...

Altria (MO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

The maker of Marlboro cigarettes reports weaker-than-expected quarterly earnings.

Altria stock is outperforming the market this year and has a high dividend yield. Altria has several qualities that benefit its shareholders.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

The program comes in response to settlements involving Juul and Altria that require substantial funding to be directed toward ...